Wells Fargo’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300K Buy
101,971
+31,912
+46% +$142K ﹤0.01% 4452
2025
Q4
$348K Sell
70,059
-1,537
-2% -$6.7K ﹤0.01% 4736
2025
Q3
$226K Buy
71,596
+8,541
+14% +$23.4K ﹤0.01% 4874
2025
Q2
$143K Sell
63,055
-11,215
-15% -$31.9K ﹤0.01% 4971
2025
Q1
$198K Sell
74,270
-663
-0.9% -$2.06K ﹤0.01% 4707
2024
Q4
$264K Buy
74,933
+5,059
+7% +$22.9K ﹤0.01% 4618
2024
Q3
$331K Sell
69,874
-6,006
-8% -$27.4K ﹤0.01% 4268
2024
Q2
$357K Buy
75,880
+7,075
+10% +$34.1K ﹤0.01% 4131
2024
Q1
$313K Sell
68,805
-1,086
-2% -$4.82K ﹤0.01% 4194
2023
Q4
$288K Sell
69,891
-51,090
-42% -$223K ﹤0.01% 4242
2023
Q3
$520K Sell
120,981
-1,512
-1% -$7.62K ﹤0.01% 3751
2023
Q2
$636K Sell
122,493
-2,030
-2% -$14.2K ﹤0.01% 3769
2023
Q1
$847K Sell
124,523
-1,447
-1% -$6.88K ﹤0.01% 3488
2022
Q4
$309K Sell
125,970
-11,998
-9% -$30.8K ﹤0.01% 3933
2022
Q3
$455K Buy
137,968
+12,995
+10% +$62K ﹤0.01% 3742
2022
Q2
$610K Buy
124,973
+119,380
+2,134% +$810K ﹤0.01% 3621
2022
Q1
$42K Hold
5,593
﹤0.01% 5733
2021
Q4
$43K Buy
5,593
+1,003
+22% +$7.88K ﹤0.01% 6036
2021
Q3
$39K Buy
4,590
+3,697
+414% +$29K ﹤0.01% 5714
2021
Q2
$8K Buy
893
+570
+176% +$5.43K ﹤0.01% 6198
2021
Q1
$3K Sell
323
-221
-41% -$2.62K ﹤0.01% 6572
2020
Q4
$4K Buy
544
+233
+75% +$1.97K ﹤0.01% 6168
2020
Q3
$3K Buy
311
+300
+2,727% +$2.75K ﹤0.01% 6069
2020
Q2
$0 Buy
11
+3
+38% +$24 ﹤0.01% 6235
2020
Q1
$0 Buy
+8
New +$77 ﹤0.01% 6133
2019
Q4
Sell
-250
Closed -$9K 6317
2019
Q3
$9K Buy
+250
New +$9.82K ﹤0.01% 5947
2015
Q1
Sell
-2
Closed -$9.82K 6136
2014
Q4
$11K Buy
+2
New +$9.78K ﹤0.01% 5577
2014
Q2
Sell
-5
Closed -$61.4K 6085
2014
Q1
$118K Buy
+5
New +$123K ﹤0.01% 4579

Other funds holding ACHV